Understanding Your Medical Test: What It Is, How It Is Performed, and What Your Results Mean for Your Health
This test detects IgG autoantibodies against cell nuclei in the blood using immunofluorescence, helping diagnose autoimmune diseases.
{"Detects homogeneous (diffuse) nuclear IgG antibodies using immunofluorescence","Used to screen for autoimmune diseases like systemic lupus erythematosus (SLE)","Positive results indicate possible autoimmune activity but require clinical correlation","No fasting required; a simple blood draw is needed","Results are reported as titers (e.g., 1:40, 1:160) with pattern classification"}
Key facts at a glance
- LOINC
- 85083-4
- Short code
- ANA IgG homogeneous Titr Ser IF
- Synonyms
- ANA IgG homogeneous Titr Ser IF
- Category
- chemistry
- Sample
- serum
- Container
- Red-top tube (SST)
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- if
- CPT
- 86038
- Specimen volume
- 5 mL
- Stability
- Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
- Hemolysis max
- 500
- Lipemia max
- 1000
- Icterus max
- 500
- TAT
- 4–24 hours
- Order
- routine
What is this test? This test is a laboratory evaluation that helps your healthcare provider learn how well your body is functioning. It may be used to screen for certain health conditions, help diagnose symptoms you are experiencing, or monitor an ongoing treatment plan.
The homogeneous nuclear IgG antibody test is a type of antinuclear antibody (ANA) test that uses immunofluorescence techniques to detect IgG antibodies targeting cell nuclei in your blood. The 'homogeneous' (also called diffuse) pattern refers to the uniform staining of the entire nucleus when viewed under a fluorescence microscope. This test helps healthcare providers screen for certain autoimmune disorders where the immune system mistakenly produces antibodies against the body's own cells.
How is the test performed? A trained member of your care team will collect a small sample, most often a blood sample drawn from a vein in your arm or a urine sample. The collection usually takes only a few minutes, and the sample is then sent to a laboratory for analysis.
A healthcare professional will draw a small blood sample from a vein in your arm. The blood sample is then sent to a laboratory where it is processed. In the lab, patient serum is mixed with specialized cells (often HEp-2 cells) on a slide. If antibodies are present, they will bind to the cell nuclei. A fluorescent dye is added, and the slide is examined under a microscope. The technologist looks for the homogeneous pattern (uniform, diffuse fluorescence throughout the nucleus) and reports the highest titer (dilution) at which fluorescence is still visible.
What do the results mean? Your results are compared with standard reference ranges. Values outside these ranges do not automatically mean you have a disease; your healthcare provider will interpret them together with your symptoms, medical history, and other findings, then explain any next steps.
Results are reported in two parts: the titer and the pattern. The titer (e.g., 1:40, 1:160, 1:640) indicates how many times the blood could be diluted and still show positive fluorescence. Higher titers generally suggest stronger antibody presence. The homogeneous pattern is commonly associated with systemic lupus erythematosus (SLE) but can also appear in other autoimmune conditions. However, a positive result does not automatically mean you have a disease—clinical symptoms and other tests must be considered together.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
The homogeneous nuclear IgG pattern is most frequently associated with systemic lupus erythematosus (SLE), one of the most common autoimmune diseases. It may also be seen in other conditions such as drug-induced lupus, rheumatoid arthritis, and scleroderma. This pattern is produced by antibodies against deoxyribonucleoprotein (DNP) and histones. While detecting this antibody pattern supports the diagnosis of autoimmune disease, it is not specific to any single condition. The test is primarily used as a screening tool—if positive, additional specific tests (like anti-dsDNA, anti-Sm, or anti-histone antibodies) are usually ordered to narrow down the diagnosis. Healthcare providers interpret results alongside clinical symptoms, physical findings, and other laboratory tests.
Frequently asked questions
Do I need to fast before this test?
Is this test painful?
What is a normal result?
Can medications affect the test results?
Do I need to stop taking my medications before the test?
How long does it take to get results?
What should I do if my result is positive?
Sources
- 1
- 2
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy